JP Morgan Reinstates Overweight on Immunocore Hldgs, Announces $60 Price Target
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Jessica Fye has reinstated Immunocore Holdings (NASDAQ:IMCR) with an Overweight rating and set a price target of $60.

November 20, 2023 | 1:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Immunocore Holdings has been reinstated by JP Morgan with an Overweight rating and a price target of $60, indicating a positive outlook for the stock.
The reinstatement of Immunocore Holdings by JP Morgan with an Overweight rating and a high price target suggests a strong bullish sentiment from the analyst. This could lead to increased investor confidence and a potential rise in the stock price in the short term, as market participants often react positively to such analyst upgrades and price target announcements.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100